Biweekly escalated, accelerated hyperfractionated radiotherapy with concomitant single-dose mitomycin C results in a high rate of local control in advanced laryngeal and hypopharyngeal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 6, 2004, Pages 589-594

  Saarilahti, Kauko ^a   Kajanti, Mikael ^a   Atula, Timo ^a   Mäkitie, Antti ^a   Aaltonen, Leena Maija ^a   Kouri, Mauri ^a   Mäntylä, Matti ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Dose escalation; Hypopharyngeal cancer; Laryngeal cancer; Mitomycin C; Radiotherapy

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; LARYNX CANCER; MALE; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; SURVIVAL ANALYSIS;

EID: 10044265307     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000135737.78861.2d     Document Type: Article

References (22)

1. Peters LJ, Ang KJ. The role of altered fractionation in head and neck cancer. Semin Radiat Oncol. 1992;2:180-194.
2. Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol. 1973;46:381-389.
3. Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol. 1992;2:16-21.
4. Withers HR, Taylor JMG, Maciejewsky B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27: 163-170.
5. Maciejewsky B, Zajusz A, Pilecki B, et al. Escalated hyperfraction and stimulation of acute mucosal reactions in radiotherapy for cancer of the oral cavity and oropharynx. Semin Radiat Oncol. 1992;2:54-57.
6. McGinn CJ, Harari PM, Fowler JF, et al. Dose intensification in curative head and neck cancer radiotherapy - linear quadratic analysis and preliminary results. Int J Radiat Oncol Biol Phys. 1993;27:363-369.
7. Kajanti M, Blomqvist C, Lehtonen H, et al. Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 1993;4:837-840.
8. Branislav J, Shibamoto Y, Stanisavljevic B, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 1997;43:29-37.
9. Al-Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;4: 1310-1317;1998.
10. Wendt TG, Grabenbauer GG, Rödel C, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998;4:1318-1324.
11. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;25:1798-1804.
12. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;24: 2081-2084.
13. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;7:1458-1464.
14. Dobrowsky W, Naudé J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol. 2000;57:119-124.
15. Shanmugaratnam K, Sobin LH, eds. Histological Typing of Upper Respiratory Tract Tumours. Geneva: WHO; 1978:14-33.
16. Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
17. Kaplan EL, Meier P, Nonparametric estimation from incomplete observations. J Natl Cancer Inst. 1958;53:437-481.
18. Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L, et al. Comparison of conventional and split-course radiotherapy as treatment in carcinoma of the larynx. Acta Oncol. 1988;27:147-152.
19. Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res. 1988;48:775-778.
20. Haffty BG, Son YH, Papac R, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck. J Clin Oncol. 1997;15:268-276.
21. Keane TJ, Cummings BJ, O'Sullivan B, et al. Randomized trial of radiation therapy compared to split-course radiation therapy combined with mitomycin C and 5-fluorouracil as initial treatment for advanced laryngeal hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys. 1993;25:613-618.
22. Terrell JE, Fisher SG, Wolf GT; for The Veterans Affairs Laryngeal Cancer Study Group. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg. 1998;124: 964-971.